Immobilized desferrioxamine (DFO) for the extracorporeal removal of aluminum.
作者信息
Anthone S, Ambrus C M, Horvath C, Kalghatgi K
机构信息
Department of Surgery, State University of New York, Buffalo.
出版信息
ASAIO Trans. 1987 Jul-Sep;33(3):744-8.
PMID:3676012
Abstract
摘要
相似文献
1
Immobilized desferrioxamine (DFO) for the extracorporeal removal of aluminum.
ASAIO Trans. 1987 Jul-Sep;33(3):744-8.
2
Treatment of aluminum overload using a cartridge with immobilized desferrioxamine.
J Am Soc Nephrol. 1995 Oct;6(4):1271-7. doi: 10.1681/ASN.V641271.
3
Removal of aluminum from chronic dialysis patients by administration of desferrioxamine and dialysis.
ASAIO Trans. 1986 Jul-Sep;32(1):52-7.
4
Desferrioxamine in the treatment of aluminum overload.去铁胺治疗铝过载。
Clin Nephrol. 1985;24 Suppl 1:S94-7.
5
Effect of desferrioxamine infusion on red blood cell aluminum.
ASAIO Trans. 1988 Jul-Sep;34(3):297-9.
6
Clearance of aluminum by hemodialysis: effect of desferrioxamine.血液透析对铝的清除：去铁胺的作用
Kidney Int Suppl. 1986 Feb;18:S100-3.
7
Desferrioxamine induced aluminium removal in haemodialysis.
Proc Eur Dial Transplant Assoc Eur Ren Assoc. 1985;21:366-70.
8
Plasma aluminum and iron kinetics in hemodialyzed patients after i.v. infusion of desferrioxamine.静脉注射去铁胺后血液透析患者的血浆铝和铁动力学
Trans Am Soc Artif Intern Organs. 1984;30:479-82.
9
[The causes, diagnosis and treatment of aluminum toxicity in patients with chronic renal failure undergoing dialysis].[接受透析的慢性肾衰竭患者铝中毒的病因、诊断及治疗]
Zhonghua Nei Ke Za Zhi. 1996 Jan;35(1):36-40.
10
Desferrioxamine versus erythropoietin for treatment of dialysis anaemia.去铁胺与促红细胞生成素治疗透析性贫血的比较
Lancet. 1990 Jun 16;335(8703):1465. doi: 10.1016/0140-6736(90)91493-t.
Zotero 插件